Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,671	1,874	1,245	1,543	1,785	3,001
Market Cap Growth	-8.96%	50.56%	-19.32%	-13.57%	-40.52%	-8.08%
Enterprise Value	450	274	448	607	488	2,644
Last Close Price	27.17	32.86	22.27	28.08	32.87	43.33
PE Ratio	-	2.78	-	-	1.11	-
PS Ratio	34.98	51.35	46.40	108.35	-	-
PB Ratio	1.23	1.22	1.54	1.40	1.38	7.51
P/TBV Ratio	1.29	1.22	1.54	1.40	1.38	7.51
EV/Sales Ratio	10.06	7.51	16.70	42.61	-	-
Debt / Equity Ratio	0.04	0.04	0.09	0.08	0.08	0.26
Asset Turnover	0.03	0.03	0.03	0.01	-	-
Inventory Turnover	11.63	13.08	21.65	-	-	-
Quick Ratio	12.81	11.06	11.49	12.54	17.17	6.07
Current Ratio	13.82	11.90	12.27	13.30	17.79	6.75
Return on Equity (ROE)	-27.57%	57.29%	-36.83%	-19.38%	-42.15%	-63.33%
Return on Assets (ROA)	-18.71%	-20.47%	-22.49%	-18.17%	-20.65%	-24.08%
Return on Invested Capital (ROIC)	-111.20%	-98.60%	-153.69%	-100.74%	-251.59%	-554.85%
Return on Capital Employed (ROCE)	-36.30%	-26.90%	-45.00%	-33.10%	-27.50%	-44.30%
Earnings Yield	-24.13%	35.95%	-28.29%	-15.02%	89.89%	-10.91%
FCF Yield	-24.90%	-20.89%	-23.87%	-20.38%	-23.14%	-10.16%
Buyback Yield / Dilution	-0.86%	-4.02%	-1.57%	9.36%	12.39%	-15.01%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q